By Timo Minssen We are pleased to announce a new publication in the International Review of Intellectual Property and Competition Law (IIC). Our paper analyzes new case law in European stem cell patenting and compares these developments with the US situation and International treaties. Further information and an abstract is available below: Authors: Ana Nordberg & Timo Minssen, University of Copenhagen, Centre…
By Maayan Sudai New Guidelines issued by the IOC (International Olympic Committee) offer a new policy for the participation of transgender athletes in sports competitions. According to the new policy, transgender athletes should be given the option to compete without having to undergo genital re-construction surgery. Female to Male (F-M) transgender athletes will be allowed…
By I. Glenn Cohen As I said in one of my earlier posts today one of the most interesting parts of the NAM report on mitochondrial replacement therapy was its recommendation that only male embryos be implanted and not female ones. The argument is that this will eliminate the risks of germ-line transmission of anything…
By I. Glenn Cohen As readers know I’ve written on mitochondrial replacement therapy and its attendant ethical and regulatory issues. Today the National Academy of Medicine (formerly known as the IOM) released a terrific report today with its recommendations. I’ll have a second post with my reactions but here is a summary from the report…
By Maayan Sudai Dutee Chand is an Indian athlete that has been in the focus of a recent drama in elite sport. Chand, a gifted athlete and champion, was suspended from participating in competitions by the International Association of Athletics Federations (IAAF), after she was found to have high levels of testosterone. A biological condition…
By Kelsey Berry This week, a research group in China published a paper describing a significant step forward in one application of the genome editing technique CRISPR: they used it to modify the genome of non-viable human embryos. Now, the scientific community finds itself grasping for ethical and legal foundations in order to evaluate the implications of this work and its…
HLS Health Law Workshop: Matt Lamkin November 3, 2014 5:00 PMGriswold Hall, Room 110 (Harvard Law School)1525 Massachusetts Ave., Cambridge, MA [Map here.] Download the paper: “Regulating Identity: Medical Regulation as Social Control” Matt Lamkin is Assistant Professor of Law at the University of Tulsa College of Law. He previously was a Fellow at Stanford Law School’s Center for…
[This message is from the students at Harvard Effective Altruism.] Welcome back to school, altruists! I’m happy to announce our first talk of the semester – from philosopher Nick Bostrom. See you there! Harvard College Effective Altruism presents: Superintelligence: Paths, Dangers, Strategies with Nick Bostrom Director of the Future of Humanity Institute at Oxford University What…
By Nathaniel Counts Politics, theoretically at least, is a process designed to enhance the sense of wellbeing of its citizens. The success of this process, the amount of wellbeing that can be created, is hamstrung by biology – we have basal levels of felt wellbeing that are determined through some amount of nature and nurture,…
By Matthew L Baum At least since the publication of the President’s Commission on Bioethics’ report in 2003, “Beyond Therapy: Biotechnology and the Pursuit of Happiness”, there has been an ongoing debate about the ethics of using drugs to modify emotional memories. Rather than focus on the Hollywood-type total memory erasure featured in the Eternal Sunshine…
